Marker Therapeutics Inc (MRKR)

[learningcurve2020]

Trial results looked great so far and the low outstanding was attractive until this lousy offering. Seems like the CEO has gone out of his way to give shares away unless there's something about the IP we do not know??

This could easily be another one of those penny bio's who's really just doing research for the true IP owners on retails dime. Meanwhile executives get paid well.

I think the CEO should be forced to address shareholders on that SA article and tell us all why no comparisons can be drawn.